Identified amplifications included several known BC amplicons and oncogenes, for example, 8p12 (FGFR1, LSM1, RAB11F1P1, PPAPDC1B), 8q24.21 (MYC), 11q13.3 (CCND1) and 20q13.2 (ZNF217). This evidence concerns the gene MYC and breast cancer.